Find the latest Leap Therapeutics, Inc. (LPTX) stock quote, history, news and other vital information to help you with your stock trading and investing.

4 days ago · Leap Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel therapies designed to treat patients with cancer. The company was founded on January 3, 2011...

3 days ago · Get a real-time Leap Therapeutics, Inc. (LPTX) stock price quote with breaking news, financials, statistics, charts and more.

Leap Therapeutics (Nasdaq: LPTX) is focused on developing targeted and immuno-oncology therapeutics. Leap’s most advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein.

2 days ago · Of course, such a phase 3 trial could be costly, so it is worth considering LPTX's financials. Financial Overview. LPTX finished Q3 '24 with $62.8M in cash and cash equivalents. R&D expense was ...

Jan 24, 2025 · Should You Buy or Sell Leap Therapeutics Stock? Get The Latest LPTX Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat.

Get the latest Leap Therapeutics Inc (LPTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

Discover real-time Leap Therapeutics, Inc. Common Stock (LPTX) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq.

2 days ago · A high-level overview of Leap Therapeutics, Inc. (LPTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

1 day ago · View Our Latest Stock Analysis on LPTX Leap Therapeutics Stock Performance. Shares of NASDAQ LPTX opened at $0.57 on Wednesday. Leap Therapeutics has a fifty-two week low of $0.55 and a fifty-two week high of $4.79. The stock has a market cap of $21.90 million, a price-to-earnings ratio of -0.30 and a beta of 0.17. The firm's 50-day simple ...